Skip to main content
. 2014 Jan 12;73(3):475–484. doi: 10.1007/s00280-013-2346-z

Table 3.

Mean concentrations of TAM and its metabolites in tumor recurrent and non-recurrent patients. Mean values of body mass index (BMI) and duration of TAM treatment for each group of patients are demonstrated in the table below

TAM (ng/g) DMT (ng/g) 4-OH (ng/g) Endoxifen (ng/g) BMI Months on TAM
Tumor recurrent patients (n = 16) 122 ± 25.2 324 ± 103 2.13 ± 0.604 19.2 ± 5.08 26.4 26
Tumor non-recurrent patients (n = 8) 147 ± 51.7 1,256 ± 282.8 9.75 ± 4.62 94.6 ± 41.0 28.6 22